Evidence map›Paper›PMID 17641968›Full record

ReviewInternational journal of health care finance and economics2007

The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care.

Braden J Manns, David C Mendelssohn, Kenneth J Taub

Abstract readReview
PubMed Publisher
In one paragraph

Review in International journal of health care finance and economics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Composite Tissue Transplant of Hand or Arm: A Health Technology Assessment.Ontario health technology assessment series · 2016
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Home Sweet Home: A Program Report on Promoting the Uptake of Home Dialysis.Canadian journal of kidney health and disease · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Is Assisted Peritoneal Dialysis a Solution for Northern Manitoba?Healthcare policy = Politiques de sante · 2019
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Braden J MannsDepartment of Medicine, University of Calgary, Calgary, T2N 2T9, AB, Canada. braden.manns@calgaryhealthregion.ca
David C Mendelssohn
Kenneth J Taub

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Examining international differences in health outcomes for end-stage renal disease (ESRD) patients requires an understanding of ESRD funding structures. In Canada, funding for all aspects of dialysis and transplant care, with the exception of drugs (for which supplementary insurance can be purchased), is provided for all citizens. Although ESRD programs across Canada's 10 provinces differ in funding structure, they share important economic characteristics, including being publicly funded and universal, and providing most facets of ESRD care for free. This paper explains how ESRD care fits into the Canadian health care system, describes the epidemiology of ESRD in Canada, and offers economic explanations for international discrepancies.

Indexed as

CanadaDelivery of Health CareDialysisGuideline AdherenceHealth ExpendituresHealth ServicesHumansKidney Failure, ChronicModels, EconometricNational Health ProgramsPractice Guidelines as TopicQuality of Health CareReimbursement Mechanisms

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.